Because we demonstrated that USP22 deubiquitinated PTEN and inhibited the degradation of PTEN, we hypothesized that USP22 induced p21 expression via PTEN in pancreatic cancer. This evidence concerns the gene USP22 and familial pancreatic carcinoma.